MedTrace Logo

Topical Rosemary Oil Application in Systemic Sclerosis

NCT03531216 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2019-01-10

No results posted yet for this study

Summary

The objectives of this prospective crossover, open-label, nonrandomized study are to estimate effect sizes of vasodilatation and sense of warmth after application of topical rosemary essential oil in patients suffering from systemic sclerosis.

Conditions

Interventions

OTHER

Rosemary essential oil

Topically-applied oil to both dorsal and palmar aspects of the hands

OTHER

Placebo

Topically-applied oil to both dorsal and palmar aspects of the hands

Sponsors & Collaborators

  • University Hospital Tuebingen

    collaborator OTHER

  • ARCIM Institute Academic Research in Complementary and Integrative Medicine

    lead OTHER

Principal Investigators

  • Jan Vagedes, Dr. · ARCIM Institute; University of Tuebingen

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-02
Primary Completion
2016-03-21
Completion
2016-03-21

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03531216 on ClinicalTrials.gov